Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Advisory committee schedule

This article was originally published in The Tan Sheet

Executive Summary

FDA's Nonprescription Drugs Advisory Committee is slated for meetings in March and June, with specific dates to be announced, according to a tentative schedule of advisory committee meetings published in the Dec. 31 Federal Register. Possible overlaps with other committees may include the Endocrinologic & Metabolic Drugs Advisory Committee, slated to meet June 22-23, the Dermatologic & Ophthalmic Drugs Advisory Committee (June 24-25) and the Pulmonary-Allergy Drugs Advisory Committee, scheduled for June 29-30...
Advertisement

Related Content

NDAC schedule
Statins Improve Survival Rate In Trial, Could Strengthen OTC Platform

Topics

Advertisement
UsernamePublicRestriction

Register

PS096344

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel